Article Text

other Versions

Download PDFPDF

Dissemination and evaluation of the ASAS/EULAR recommendations for the management of Ankylosing Spondylitis: results of a study among 1,507 rheumatologists.
  1. Laure Gossec (laure.gossec{at}
  1. Paris Descartes University, France
    1. Maxime Dougados
    1. Paris Descartes University, France
      1. Charles Phillips
      1. Wyeth Europa, United Kingdom
        1. Mohammed Hammoudeh
        1. Hamad Medical corporation, Doha, Qatar
          1. Kurt de Vlam
          1. University Hospital Leuven, Belgium
            1. Karel Pavelka
            1. Charles University, Prague, Czech Republic
              1. Thao Pham
              1. Conception Hospital, AP-HM, Marseille, France
                1. Juergen Braun
                1. Rheumazentrum Ruhrgebiet, Germany
                  1. Joachim Sieper
                  1. Medical Department I, Charité, Campus Benjamin Franklin, Berlin, Germany
                    1. Ignazio Olivieri
                    1. San Carlo Hospital of Potenza and Madonna delle Grazie Hospital, Italy
                      1. Désirée van der Heijde
                      1. University Medical Center, Leiden, Netherlands
                        1. Eduardo Collantes
                        1. University Hospital Reina Sofía. Cordoba, Spain
                          1. Millicent A Stone
                          1. University of Bath and University of Toronto, United Kingdom
                            1. Tore K Kvien
                            1. Diakonhjemmet Hospital, Oslo, Norway


                              Background: Ten ASAS/EULAR recommendations for the management of ankylosing spondylitis (AS) were published in 2006. The objectives of this study were (a) to disseminate and (b) to evaluate conceptual agreement with, and (c) application of, these recommendations as well as (d) potential barriers to the application.

                              Methods: A questionnaire was sent out to rheumatologists in 10 countries. The questionnaire included (a) the text of the recommendations; (b) rheumatologists’ demographic variables; (c) 2 numerical rating scales (NRS) from 1 to 10 for each recommendation: conceptual agreement with, and application of, the recommendation (10 indicates maximal agreement and maximal application); and (d) a list of potential barriers to the application of the recommendation. Statistical analysis included descriptive and multivariate analyses.

                              Results: A total of 7206 questionnaires were sent out; 1507 (21%) were returned. Of the 1507 answering rheumatologists, 62% were men, mean age 49±9 yrs, and 34% had an academic position. Conceptual agreement with the recommendations was high (mean±SD for all recommendations 8.9±0.9). Self-reported application was also high (8.2±1.0). The difference between agreement and application varied across recommendations and countries. The most pronounced discrepancies were reported for use of anti-TNF drugs in a few countries with funding as the most frequently reported barrier for application of this recommendation.

                              Conclusion: This large project has helped the dissemination of the ASAS/EULAR recommendations for the management of AS and shows that conceptual agreement with the recommendations is very high. The project also highlights inequalities in access to health care for European citizens with AS.

                              • Ankylosing spondylitis,
                              • dissemination,
                              • evaluation,
                              • implementation
                              • recommendations,

                              Statistics from

                              Request Permissions

                              If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.